NCT03851055View on ClinicalTrials.gov

Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

July 10, 2018

Study Completion Date

August 28, 2018

Conditions
Beta-thalassemia Major Complicated With Diabetes
Interventions
DRUG

Zinc

One arm will receive Zinc Second arm will receive placebo

Trial Locations (1)

11361

Nancy Elbarbary, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03851055 - Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus | Biotech Hunter | Biotech Hunter